Expression of CXCL14 and its anticancer role in breast cancer

Breast Cancer Research and Treatment

Volumn 135, Issue 3, 2012, Pages 725-735

  Gu, Xiao Li ^a   Ou, Zhou Luo ^a   Lin, Feng Juan ^a   Yang, Xiao Li ^a   Luo, Jian Min ^a   Shen, Zhen Zhou ^a   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Breast cancer; Chemokine; CXCL14; Metastasis

Indexed keywords

CXCL14 CHEMOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CANCER THERAPY; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE TRANSFECTION; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING;

ADULT; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINES, CXC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE; MICE, SCID; MIDDLE AGED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866528153     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2206-2     Document Type: Article

References (32)

1. Chalasani P, Downey L, Stopeck AT (2010) Caring for the breast cancer survivor: a guide for primary care physicians. Am J Med 123(6):489-495
2. Balkwill F (2003) Chemokine biology in cancer. Semin Immunol 15(1):49-55 (Pubitemid 36092178)
3. Zlotnik A, Yoshie O, Nomiyama H (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7(12):11
4. Rollins BJ (2006) Inflammatory chemokines in cancer growth and progression. Eur J Cancer 42(6):760-767
5. Zlotnik A (2006) Chemokines and cancer. Int J Cancer 119(9): 2026-2029 (Pubitemid 44423657)
6. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12(2):121-127 (Pubitemid 30398626)
7. Darash-Yahana M, Gillespie JW, Hewitt SM, Chen YYK, Maeda S, Stein I, Singh SP, Bedolla RB, Peled A, Troyer DA, Pikarsky E, Karin M, Farber JM (2009) The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammationassociated cancers. PLoS One 4(8):12
8. Hromas R, Broxmeyer HE, Kim C, Nakshatri H, Christopherson K 2nd, Azam M, HouYH(1999) Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun 255(3):703-706 (Pubitemid 29294862)
9. McKinnon CM, Lygoe KA, Skelton L, Mitter R, Mellor H (2008) The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells. Oncogene 27(54):6856-6865
10. Kurth I, Willimann K, Schaerli P, Hunziker T, Clark-Lewis I, Moser B (2001) Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J Exp Med 194(6):855-861 (Pubitemid 32983020)
11. Starnes T, Rasila KK, Robertson MJ, Brahmi Z, Dahl R, Christopherson K, Hromas R (2006) The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy. Exp Hematol 34(8): 1101-1105 (Pubitemid 44080391)
12. Shellenberger TD, Wang M, Gujrati M, Jayakumar A, Strieter RM, Burdick MD, Ioannides CG, Efferson CL, El-Naggar AK, Roberts D, Clayman GL, Frederick MJ (2004) BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res 64(22):8262-8270 (Pubitemid 39496830)
13. Shurin GV, Ferris RL, Tourkova IL, Perez L, Lokshin A, Balkir L, Collins B, Chatta GS, Shurin MR (2005) Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J Immunol 174(9):5490-5498 (Pubitemid 40593189)
14. Tessema M, Klinge DM, Yingling CM, Do K, Van Neste L, Belinsky SA (2010) Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. Oncogene 29(37):5159-5170
15. Song EY, Shurin MR, Tourkova IL, Gutkin DW, ShurinGV(2008) Epigenetic mechanisms of promigratory chemokine CXCL14 Regulation in human prostate cancer cells. Cancer Res 70(11): 4394-4401
16. Schwarze SR, Luo J, Isaacs WB, Jarrard DF (2005) Modulation of CXCL14 (BRAK) expression in prostate cancer. Prostate 64(1): 67-74 (Pubitemid 40734740)
17. Wente MN, Mayer C, Gaida MM, Michalski CW, Giese T, Bergmann F, Giese NA, Buchler MW, Friess H (2008) CXCL14 expression and potential function in pancreatic cancer. Cancer Lett 259(2):209-217 (Pubitemid 350251641)
18. Chiu SH, Chen CC, Lin TH (2008) Using support vector regression to model the correlation between the clinical metastases time and gene expression profile for breast cancer. Artif Intell Med 44(3):221-231
19. Pelicano H, Lu W, Zhou Y, Zhang W, Chen Z, Hu Y, Huang P (2009) Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Res 69(6):2375-2383
20. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23(36):9067-9072
21. Hayes DF, Ethier S, Lippman ME (2006) New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK. Breast Cancer Res Treat 100(2):237-238 (Pubitemid 44631926)
22. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2006) REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100(2):229-235 (Pubitemid 44631925)
23. Li JY, Ou ZL, Yu SJ, Gu XL, Yang C, Chen AX, Di GH, Shen ZZ, Shao ZM (2012) The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer. Breast Cancer Res Treat 131(3):837-848
24. Jones LW, Viglianti BL, Tashjian JA, Kothadia SM, Keir ST, Freedland SJ, Potter MQ, Moon EJ, Schroeder T, Herndon JE, Dewhirst MW (2010) Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer. J Appl Physiol 108(2):343-348
25. Yu KD, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM (2007) Development and trends of surgical modalities for breast cancer in China: a review of 16-year data. Ann Surg Oncol 14(9):2502-2509
26. Sato K, Ozawa S, Izukuri K, Kato Y, Hata R (2010) Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro. Cell Biol Int 34(5):513-522
27. Izukuri K, Suzuki K, Yajima N, Ozawa S, Ito S, Kubota E, Hata RI (2010) Chemokine CXCL14/BRAKtransgenic mice suppress growth of carcinoma cell xenografts. Transgenic Res 19(6):1109-1117
28. Ito S, Ozawa S, Ikoma T, Yajima N, Kiyono T, Hata RI (2010) Expression of a chemokine BRAK/CXCL14 in oral floor carcinoma cells reduces the settlement rate of the cells and suppresses their proliferation in vivo. Biomed Res 31(3):199-206
29. Ozawa S, Kato Y, Kubota E, Hata RI (2009) BRAK/CXCL14 expression in oral carcinoma cells completely suppresses tumor cell xenografts in SCID mouse. Biomed Res 30(5):315-318
30. Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2(2):123-128 (Pubitemid 33707929)
31. Kleer CG, Bloushtain-Qimron N, Chen YH, Carrasco D, Hu M, Yao J, Kraeft SK, Collins LC, Sabel MS, Argani P, Gelman R, Schnitt SJ, Krop IE, Polyak K (2008) Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Clin Cancer Res 14(17):5357-5367
32. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6(1): 17-32 (Pubitemid 38903159)